Xiufan Liu Selected Research

Complement System Proteins (Complement)

4/2017	iTRAQ-based quantitative proteomics reveals important host factors involved in the high pathogenicity of the H5N1 avian influenza virus in mice.
8/2016	PA-X-associated early alleviation of the acute lung injury contributes to the attenuation of a highly pathogenic H5N1 avian influenza virus in mice.
1/2015	RstA is required for the virulence of an avian pathogenic Escherichia coli O2 strain E058.
6/2013	RfaH promotes the ability of the avian pathogenic Escherichia coli O2 strain E058 to cause avian colibacillosis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Xiufan Liu Research Topics

Disease

72	Influenza in Birds (Avian Flu) 05/2024 - 06/2002
57	Infections 05/2024 - 04/2002
14	Virus Diseases (Viral Diseases) 12/2024 - 03/2009
13	Human Influenza (Influenza) 05/2024 - 11/2010
5	Neoplasms (Cancer) 02/2024 - 07/2014
3	Newcastle Disease 11/2022 - 03/2011
3	Rheumatoid Arthritis 12/2020 - 01/2020
3	Viremia 01/2020 - 07/2015
2	Inflammation (Inflammations) 07/2020 - 11/2017
2	Body Weight (Weight, Body) 02/2020 - 01/2020
2	Necrosis 10/2018 - 09/2012
2	Lung Injury 04/2017 - 08/2016
1	Coinfection 05/2024
1	Coronavirus Infections 12/2020
1	Dehydration (Water Stress) 06/2020

Drug/Important Bio-Agent (IBA)

41	VaccinesIBA 05/2024 - 02/2009
31	Proteins (Proteins, Gene)FDA Link 12/2024 - 04/2002
29	Hemagglutinins (Hemagglutinin)IBA 05/2024 - 06/2002
15	Neuraminidase (Sialidase)IBA 05/2024 - 10/2008
9	Antiviral Agents (Antivirals)IBA 12/2024 - 08/2013
8	Amino Acids FDA Link 09/2023 - 06/2002
8	EpitopesIBA 08/2022 - 03/2013
8	AntibodiesIBA 08/2022 - 03/2018
5	IronIBA 02/2024 - 07/2012
5	Inactivated VaccinesIBA 01/2022 - 04/2010
4	NucleotidesIBA 01/2023 - 08/2003
4	RNA (Ribonucleic Acid)IBA 01/2023 - 01/2019
4	Complement System Proteins (Complement)IBA 04/2017 - 06/2013
3	Influenza Vaccines (Influenza Vaccine)FDA Link 05/2024 - 01/2012
3	HN ProteinIBA 05/2024 - 03/2011
3	Viral ProteinsIBA 12/2023 - 08/2014
3	CytokinesIBA 12/2023 - 08/2013
3	Peptides (Polypeptides)IBA 12/2022 - 10/2021
3	Small Interfering RNA (siRNA)IBA 01/2022 - 11/2008
3	MicroRNAs (MicroRNA)IBA 01/2021 - 01/2019
2	Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA 02/2024 - 01/2022
2	AntigensIBA 12/2023 - 08/2022
2	Monoclonal AntibodiesIBA 04/2023 - 01/2022
2	Long Noncoding RNAIBA 01/2023 - 12/2021
2	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2022 - 04/2017
2	Matrix Metalloproteinases (MMPs)IBA 01/2022 - 01/2018
2	CollagenIBA 01/2021 - 01/2018
2	teriflunomideIBA 12/2020 - 01/2020
2	Leflunomide (Arava)FDA LinkGeneric 12/2020 - 01/2020
2	Neutralizing AntibodiesIBA 11/2020 - 01/2019
2	Janus Kinase InhibitorsIBA 10/2020 - 01/2020
2	Janus KinasesIBA 10/2020 - 01/2020
2	Immunoglobulin A (IgA)IBA 09/2020 - 04/2010
2	DNA (Deoxyribonucleic Acid)IBA 01/2020 - 11/2016
2	Synthetic Vaccines (Recombinant Vaccines)IBA 12/2018 - 05/2012
2	Attenuated VaccinesIBA 01/2018 - 01/2017
2	sialic acid receptorIBA 01/2017 - 01/2016
2	Immunologic Adjuvants (Immunologic Adjuvant)IBA 01/2017 - 01/2016
2	EmulsionsIBA 01/2016 - 01/2012
2	Virulence Factors (Pathogenicity Factors)IBA 10/2013 - 07/2008
1	Virus-Like Particle VaccinesIBA 05/2024
1	UbiquitinIBA 02/2024
1	Cathepsin BIBA 02/2024
1	Immunodominant EpitopesIBA 12/2023
1	VimentinIBA 10/2023
1	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2023
1	AerosolsIBA 01/2023
1	Sulfides (Thioethers)IBA 01/2023
1	Therapeutic UsesIBA 01/2023
1	ChemokinesIBA 12/2022
1	Combined VaccinesIBA 05/2022
1	Indicators and Reagents (Reagents)IBA 01/2022
1	OccludinIBA 01/2022
1	triphosphoric acid (triphosphate)IBA 01/2022
1	6- deoxy- N- (7- nitrobenz- 2- oxa- 1,3- diazol- 4- yl)aminoglucose (NBDG)IBA 01/2022
1	mesoxalonitrileIBA 01/2022
1	Adenosine Monophosphate (AMP)IBA 01/2022
1	Adenosine Triphosphate (ATP)IBA 01/2022
1	Carbonyl Cyanide m-Chlorophenyl Hydrazone (CCCP)IBA 01/2022
1	Deoxyglucose (2 Deoxy D glucose)IBA 01/2022
1	Glucose (Dextrose)FDA LinkGeneric 01/2022
1	NAD (NADH)IBA 01/2022
1	Phosphotransferases (Kinase)IBA 01/2022
1	Tricarboxylic AcidsIBA 01/2022
1	AMP-Activated Protein KinasesIBA 01/2022
1	Sirtuin 3IBA 01/2022
1	RNA Precursors (Precursor, mRNA)IBA 12/2021
1	Marker VaccinesIBA 10/2021
1	N-Acetylneuraminic Acid (Sialic Acid)IBA 03/2021
1	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 01/2021
1	Methionine (L-Methionine)FDA Link 11/2020
1	Immunomodulating AgentsIBA 10/2020
1	ferric oxide (iron oxide)IBA 09/2020
1	ChitosanIBA 09/2020
1	EnzymesIBA 07/2020
1	Inositol (Myoinositol)IBA 07/2020
1	LithiumIBA 06/2020
1	potassium niobateIBA 06/2020
1	PotassiumIBA 06/2020
1	Ion Channels (Ion Channel)IBA 06/2020
1	EnterobactinIBA 04/2020
1	SiderophoresIBA 04/2020
1	SuspensionsIBA 03/2019

Therapy/Procedure

3	Therapeutics 02/2024 - 12/2021
2	Intranasal Administration 01/2012 - 11/2010